Avacincaptad pegol may help postpone driving restrictions or loss of driving eligibility in patients with geographic atrophy, according to a post hoc analysis of the GATHER1 and GATHER2 trials.
“Losing the ability to drive is a significant milestone for people as it places a burden on support systems and negatively affects the psychosocial well-being of the patients,” Seenu M. Hariprasad, MD, of the University of Chicago, said at the American Society of Retina Specialists annual meeting. “It is important to consider how treatments that can slow GA growth could also (Read more...)